On the relationship between response to treatment and survival time

Statistics in Medicine
Marc Buyse, P Piedbois

Abstract

In this paper we review several approaches which have been used to investigate the relationship between survival time and response to treatment. We show that the approaches based on summary data are subjected to various types of biases (publication bias, confounding by prognostic features, ecologic bias) and are therefore of doubtful value. We also discuss several approaches based on individual patient data. Comparisons of survival by response are generally subject to length-biased sampling, and are therefore inadequate. The landmark method is adequate when responses occur soon after starting treatment, but not when responses may appear later in the course of the disease. For responses which can occur over extended periods of time, response must be considered as a time-dependent covariate. Using data from randomized trials in advanced colorectal cancer, we show that response is a potent and independent prognostic factor for survival in this disease. Analyses using the landmark method yield results essentially equivalent to those in which response is considered as a time-dependent covariate. The hazard rate of responders is about half that of non-responders, after taking the patient's performance status into account. The issue o...Continue Reading

Citations

Feb 27, 2013·Journal of Biopharmaceutical Statistics·Cong ChenChih-Lin Li
Apr 25, 2012·Journal of Biomedicine & Biotechnology·Yanni HuHong Zhang
Nov 26, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniela MateiMichael J Birrer
Oct 26, 2005·Neurosurgical Focus·Fred G Barker, Bob S Carter
Jan 24, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P ByströmB Glimelius
Aug 13, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C SuzukiB Glimelius
Sep 15, 2012·Acta Oncologica·Per ByströmBengt Glimelius
Aug 20, 2015·Research Synthesis Methods·Thomas P A DebrayUNKNOWN GetReal Methods Review Group
Jul 16, 2008·Journal of Clinical Epidemiology·Jan BeyersmannMartin Schumacher
Oct 7, 2008·Statistics in Medicine·Jan BeyersmannMartin Schumacher
Feb 1, 2006·International Journal of Radiation Oncology, Biology, Physics·Baldassarre SteaUNKNOWN REACH Study Group
Dec 3, 2013·Journal of Clinical Epidemiology·Edward J MillsGordon H Guyatt
Jul 28, 2016·American Journal of Epidemiology·Mohammad Ehsanul KarimUNKNOWN Long-Term Benefits and Adverse Effects of Beta-Interferon for Multiple Sclerosis (BeAMS) Study Group
Jan 18, 2007·Journal of the National Cancer Institute·Stephen L George
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tomasz BurzykowskiPatrick Therasse
Jun 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paolo BruzziMarco Venturini
Sep 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bo GronlundHeine H Hansen
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Aimery de GramontChristophe Tournigand
Jun 21, 2014·Statistical Methods in Medical Research·Asc ConlonM R Elliott
May 16, 2017·The Breast Journal·Thomas FilleronFlorence Dalenc
Dec 25, 2008·Expert Review of Anticancer Therapy·Philip Abraham Kovoor, Jimmy Hwang
Oct 19, 2017·Cancer Chemotherapy and Pharmacology·Naminatsu TakaharaKazuhiko Koike
Dec 11, 2014·Clinical Trials : Journal of the Society for Clinical Trials·Jeremy M G TaylorMichael R Elliott
May 19, 2011·Circulation. Cardiovascular Quality and Outcomes·Urania Dafni
Nov 27, 2018·American Journal of Epidemiology·David WatsonJill Dreyfus
May 19, 2010·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Michael HaasStefan Boeck
Oct 14, 2005·Journal of Pharmacokinetics and Pharmacodynamics·Ferdinand RomboutUNKNOWN COST B15 Experts
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F CardenalR Rosell
Jul 4, 2002·Annals of the New York Academy of Sciences·Paolo Bruzzi
Feb 6, 2019·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Charity J Morgan
Jul 6, 2019·Statistics in Medicine·Matthias MellerKaspar Rufibach
Apr 23, 2003·Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society·B Glimelius

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.